Research location
Madison
Tennessee, United States
Advertisement
Research activity in Madison
Tennessee, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Madison
8 linked trials · page 1 of 1Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With SchizophreniaNCT00604760 · 2007-12-01 · 1 site observation
UNKNOWN
Effect of Platelet Concentrate in Treatment of Diabetic UlcersNCT00215735 · 2004-06-01 · 1 site observation
TERMINATED
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseNCT00088673 · 2004-06-01 · 1 site observation
UNKNOWN
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)NCT00093951 · 2004-04-01 · 1 site observation
COMPLETED
A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderNCT00368030 · 2004-01-01 · 1 site observation
COMPLETED
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderNCT00100776 · 2003-09-01 · 1 site observation
COMPLETED
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.NCT00151502 · 2002-11-01 · 1 site observation
COMPLETED
Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaNCT00051298 · 2002-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.